{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Bimatoprost+Solution+2", "query": { "intervention": "Bimatoprost Solution 2" }, "page_size": 10 }, "pagination": { "page": 1, "page_size": 10, "total_count": 24, "total_pages": 3, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Bimatoprost+Solution+2&page=2&page_size=10", "previous_page_url": null }, "source": "remote", "last_synced_at": "2026-09-13T20:24:16.136Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT01170884", "title": "Comparing Safety and Efficacy of Combigan® and Lumigan® With Lumigan® Alone in Glaucoma or Ocular Hypertension Subjects Treated With Xalatan®", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Glaucoma", "Ocular Hypertension" ], "interventions": [ { "name": "fixed combination of brimonidine tartrate 0.2% timolol maleate 0.5% ophthalmic solution; bimatoprost 0.03% ophthalmic solution", "type": "DRUG" }, { "name": "bimatoprost 0.03% ophthalmic solution; hypromellose 0.2% eyedrops", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Allergan", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 121, "start_date": "2009-12", "completion_date": "2010-09", "has_results": true, "last_update_posted_date": "2019-04-24", "last_synced_at": "2026-09-13T20:24:16.136Z", "location_count": 1, "location_summary": "Dallas, Texas", "locations": [ { "city": "Dallas", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT01170884" }, { "nct_id": "NCT01915940", "title": "Bimatoprost Ocular Insert Compared to Topical Timolol Solution in Patients With Glaucoma or Ocular Hypertension", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Primary Open-Angle Glaucoma", "Ocular Hypertension" ], "interventions": [ { "name": "Bimatoprost", "type": "DRUG" }, { "name": "Timolol 0.5%", "type": "DRUG" }, { "name": "Placebo Eye Drops", "type": "DRUG" }, { "name": "Placebo Ocular Insert", "type": "DEVICE" } ], "intervention_types": [ "DRUG", "DEVICE" ], "sponsor": "ForSight Vision5, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 169, "start_date": "2013-10-23", "completion_date": "2014-11-14", "has_results": true, "last_update_posted_date": "2018-04-20", "last_synced_at": "2026-09-13T20:24:16.136Z", "location_count": 10, "location_summary": "Artesia, California • La Jolla, California • Newport Beach, California + 7 more", "locations": [ { "city": "Artesia", "state": "California" }, { "city": "La Jolla", "state": "California" }, { "city": "Newport Beach", "state": "California" }, { "city": "Sacramento", "state": "California" }, { "city": "Atlanta", "state": "Georgia" } ], "official_url": "https://clinicaltrials.gov/study/NCT01915940" }, { "nct_id": "NCT00652496", "title": "Safety and Efficacy Study of Different Formulations of Bimatoprost Once-Daily in Patients With Glaucoma or Ocular Hypertension", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Glaucoma", "Ocular Hypertension" ], "interventions": [ { "name": "Bimatoprost 0.01% ophthalmic solution", "type": "DRUG" }, { "name": "Bimatoprost 0.015% formulation 1 ophthalmic solution", "type": "DRUG" }, { "name": "Bimatoprost 0.015% formulation 2 ophthalmic solution", "type": "DRUG" }, { "name": "Bimatoprost 0.02% ophthalmic solution", "type": "DRUG" }, { "name": "Bimatoprost 0.03% ophthalmic solution", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Allergan", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 249, "start_date": "2005-01", "completion_date": "2005-05", "has_results": false, "last_update_posted_date": "2008-04-03", "last_synced_at": "2026-09-13T20:24:16.136Z", "location_count": 1, "location_summary": "Wenatchee, Washington", "locations": [ { "city": "Wenatchee", "state": "Washington" } ], "official_url": "https://clinicaltrials.gov/study/NCT00652496" }, { "nct_id": "NCT04499248", "title": "AGN-193408 SR in the Treatment of Open-angle Glaucoma or Ocular Hypertension", "overall_status": "ACTIVE_NOT_RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1", "PHASE2" ], "conditions": [ "Open-angle Glaucoma", "Ocular Hypertension" ], "interventions": [ { "name": "AGN-193408 SR", "type": "DRUG" }, { "name": "Lumigan", "type": "OTHER" }, { "name": "Sham Administration", "type": "OTHER" }, { "name": "Lumigan Vehicle", "type": "OTHER" } ], "intervention_types": [ "DRUG", "OTHER" ], "sponsor": "AbbVie", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 100, "start_date": "2020-11-16", "completion_date": "2029-04", "has_results": false, "last_update_posted_date": "2026-05-22", "last_synced_at": "2026-09-13T20:24:16.136Z", "location_count": 42, "location_summary": "Sun City, Arizona • Glendale, California • Inglewood, California + 38 more", "locations": [ { "city": "Sun City", "state": "Arizona" }, { "city": "Glendale", "state": "California" }, { "city": "Inglewood", "state": "California" }, { "city": "Irvine", "state": "California" }, { "city": "Newport Beach", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT04499248" }, { "nct_id": "NCT04890106", "title": "Bioequivalence Study With Clinical Endpoint Comparing Bimatoprost Ophthalmic Solution 0.01% to LUMIGAN® In The Treatment of Chronic Open-Angle Glaucoma", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Glaucoma, Open-Angle" ], "interventions": [ { "name": "Test - Bimatoprost 0.01% Ophthalmic Solution", "type": "DRUG" }, { "name": "Reference - LUMIGAN® (Bimatoprost 0.01% Ophthalmic Solution)", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Mankind Pharma Limited", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 310, "start_date": "2021-10-02", "completion_date": "2022-08-11", "has_results": false, "last_update_posted_date": "2022-12-13", "last_synced_at": "2026-09-13T20:24:16.136Z", "location_count": 9, "location_summary": "Bakersfield, California • Mission Hills, California • Newport Beach, California + 5 more", "locations": [ { "city": "Bakersfield", "state": "California" }, { "city": "Mission Hills", "state": "California" }, { "city": "Newport Beach", "state": "California" }, { "city": "Newport Beach", "state": "California" }, { "city": "Pasadena", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT04890106" }, { "nct_id": "NCT02448043", "title": "Cutaneous Prostaglandin Application: Nail Growth, Nail Brittleness, and Eye Pressure", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Nail Growth Cessation", "Intraocular Pressure" ], "interventions": [ { "name": "Bimatoprost 0.01%", "type": "DRUG" }, { "name": "Placebo: saline", "type": "OTHER" } ], "intervention_types": [ "DRUG", "OTHER" ], "sponsor": "Northwestern University", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 45, "start_date": "2015-06-04", "completion_date": "2016-05-06", "has_results": true, "last_update_posted_date": "2019-12-13", "last_synced_at": "2026-09-13T20:24:16.136Z", "location_count": 1, "location_summary": "Glenview, Illinois", "locations": [ { "city": "Glenview", "state": "Illinois" } ], "official_url": "https://clinicaltrials.gov/study/NCT02448043" }, { "nct_id": "NCT01904721", "title": "A Safety and Efficacy Study of Bimatoprost in Men With Androgenic Alopecia (AGA)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Alopecia", "Alopecia, Androgenetic", "Baldness" ], "interventions": [ { "name": "Bimatoprost Solution 1", "type": "DRUG" }, { "name": "Bimatoprost Solution 2", "type": "DRUG" }, { "name": "Bimatoprost Vehicle", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Allergan", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "49 Years", "sex": "MALE", "summary": "18 Years to 49 Years · Male only" }, "enrollment_count": 244, "start_date": "2013-08", "completion_date": "2015-01", "has_results": true, "last_update_posted_date": "2016-03-22", "last_synced_at": "2026-09-13T20:24:16.136Z", "location_count": 1, "location_summary": "Fridley, Minnesota", "locations": [ { "city": "Fridley", "state": "Minnesota" } ], "official_url": "https://clinicaltrials.gov/study/NCT01904721" }, { "nct_id": "NCT06267274", "title": "A Randomized, Double-blind, Parallel-group, Two-arm, Multiple Dose, Multicenter, Bioequivalence Study With Clinical Endpoint in the Treatment of Subjects With Chronic Open-angle Glaucoma or Ocular Hypertension in Both Eyes", "overall_status": "UNKNOWN", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Open-angle Glaucoma", "Ocular Hypertension" ], "interventions": [ { "name": "Bimatoprost Ophthalmic Solution, 0.01%", "type": "DRUG" }, { "name": "LUMIGAN® (bimatoprost ophthalmic solution) 0.01%", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Amneal Pharmaceuticals, LLC", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 240, "start_date": "2024-04-01", "completion_date": "2025-05-01", "has_results": false, "last_update_posted_date": "2024-08-06", "last_synced_at": "2026-09-13T20:24:16.136Z", "location_count": 4, "location_summary": "Bakersfield, California • Newport Beach, California • Morrow, Georgia + 1 more", "locations": [ { "city": "Bakersfield", "state": "California" }, { "city": "Newport Beach", "state": "California" }, { "city": "Morrow", "state": "Georgia" }, { "city": "Houston", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT06267274" }, { "nct_id": "NCT01110499", "title": "Safety and Efficacy of AGN-210961 Ophthalmic Solution Compared With Bimatoprost Ophthalmic Solution in Patients With Glaucoma or Ocular Hypertension", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Ocular Hypertension", "Primary Open-Angle Glaucoma" ], "interventions": [ { "name": "AGN-210961 Formulation 1", "type": "DRUG" }, { "name": "AGN-210961 Formulation 2", "type": "DRUG" }, { "name": "AGN-210961 Formulation 3", "type": "DRUG" }, { "name": "AGN-210961 Formulation 4", "type": "DRUG" }, { "name": "AGN-210961 Formulation 5", "type": "DRUG" }, { "name": "AGN-210961 Formulation 6", "type": "DRUG" }, { "name": "AGN-210961 Formulation 7", "type": "DRUG" }, { "name": "bimatoprost ophthalmic solution 0.03%", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Allergan", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 163, "start_date": "2010-06", "completion_date": "2011-06", "has_results": true, "last_update_posted_date": "2014-08-05", "last_synced_at": "2026-09-13T20:24:16.136Z", "location_count": 1, "location_summary": "Newport Beach, California", "locations": [ { "city": "Newport Beach", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT01110499" }, { "nct_id": "NCT01291108", "title": "Safety and Efficacy of AGN-210669 Ophthalmic Solution Compared With Bimatoprost Ophthalmic Solution in Patients With Open-Angle Glaucoma or Ocular Hypertension", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Glaucoma, Open-Angle", "Ocular Hypertension" ], "interventions": [ { "name": "AGN-210669", "type": "DRUG" }, { "name": "bimatoprost", "type": "DRUG" }, { "name": "bimatoprost vehicle", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Allergan", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 125, "start_date": "2011-04", "completion_date": "2011-10", "has_results": true, "last_update_posted_date": "2013-11-06", "last_synced_at": "2026-09-13T20:24:16.136Z", "location_count": 1, "location_summary": "Austin, Texas", "locations": [ { "city": "Austin", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT01291108" } ] }